Australian Clinical Labs LtdASX: ACL

Appendix 4D and 1H24 financial reports

· Issued by Australian Clinical Labs Ltd

Filed with ASX · · 25 pages · English

Summary by 6ix AI

The report indicates a significant decline in both total revenue and profit compared to the previous half-year period. The company attributes the revenue decline to various macroeconomic challenges and a decrease in COVID-related testing revenue.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Australian Clinical Labs Ltd on 6ix

In the deck

Earlier from Australian Clinical Labs

Later from Australian Clinical Labs

All Australian Clinical Labs news releases